Form 4: STERIS CEO Carestio Reports Routine Share Vesting

STERIS plc CEO Daniel A. Carestio reported the vesting of 289 restricted shares and the withholding of 130 shares for tax purposes on October 1, 2025, a standard executive compensation event.

Summary

• Daniel A. Carestio, President and CEO of STERIS plc, reported a change in his beneficial ownership of ordinary shares.
• On October 1, 2025, 289 restricted ordinary shares, which were originally awarded on October 1, 2021, vested.
• 130 of these ordinary shares were withheld by the issuer to satisfy tax obligations associated with the vesting event.
• Following this transaction, Carestio beneficially owns a total of 51,255 ordinary shares.
• Of the beneficially owned shares, 33,054 remain restricted, with scheduled vesting dates extending through June 2028.

Sentiment

Score: 7

Explanation: The filing reports a routine and expected executive compensation event (restricted stock vesting and tax withholding). This is a neutral to slightly positive event as it demonstrates the functioning of the company's long-term incentive plan and aligns executive interests with shareholders, without indicating any operational or financial surprises.

Positives

• The vesting of 289 restricted shares for Daniel A. Carestio indicates the successful realization of long-term incentive compensation.
• Carestio's continued beneficial ownership of 51,255 ordinary shares, including a significant restricted portion, aligns his interests with those of shareholders.

Negatives

• No direct negative financial implications are indicated by this routine tax-related transaction.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction reinforces the alignment of executive interests with shareholder value through equity ownership.
• Employees: The filing reflects standard executive compensation practices, which can serve as a benchmark for other employees' equity incentive programs.

Next Steps

• Future vesting of 33,054 restricted ordinary shares on various dates between June 2026 and June 2028, as detailed in the filing.

Key Dates

Recommendation

This Form 4 filing reports a routine vesting of restricted stock and subsequent tax withholding for a key executive. Such transactions are standard components of executive compensation and do not typically indicate a change in the company's fundamental performance or outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

STERIS, STE, Form 4, Insider Transaction, Share Vesting, Executive Compensation, Daniel Carestio, Restricted Stock